184 related articles for article (PubMed ID: 35361145)
21. Primary gastric amyloidosis associated with linitis plastica and delayed progression to systemic amyloidosis and multiple myeloma.
Khalil G; Fiani D; Antaki F; Diab E
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37247951
[TBL] [Abstract][Full Text] [Related]
22. A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis.
Innocenti S; Bacchi B; Allinovi M; Perfetto F; Antonioli E; Marchionni N; Di Mario C; Caroti L; Cappelli F; Stefàno P
BMC Nephrol; 2022 Nov; 23(1):370. PubMed ID: 36397026
[TBL] [Abstract][Full Text] [Related]
23. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.
Montseny JJ; Kleinknecht D; Meyrier A; Vanhille P; Simon P; Pruna A; Eladari D
Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173
[TBL] [Abstract][Full Text] [Related]
25. AL-Kappa Primary Amyloidosis with Apolipoprotein A-IV Deposition.
Ishimitsu A; Tojo A; Hirao J; Yokoyama S; Ohira T; Murayama Y; Ishimitsu T; Kang D; Honda K; Ehara T; Ishida K; Ueda Y
Intern Med; 2022; 61(6):871-876. PubMed ID: 35296622
[TBL] [Abstract][Full Text] [Related]
26. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of histopathological scoring and grading in patients with renal AA amyloidosis.
Ozdemir A; Yılmaz M; Ozagari AA; Kocak SY
Int Urol Nephrol; 2022 Oct; 54(10):2591-2597. PubMed ID: 35275358
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of renal light chain (AL) amyloidosis with bortezomib and dexamethasone (VD).
Huang B; Li J; Xu X; Zheng D; Zhou Z; Liu J
Pathol Biol (Paris); 2015 Feb; 63(1):17-20. PubMed ID: 25455933
[TBL] [Abstract][Full Text] [Related]
29. The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry.
Gonzalez Suarez ML; Zhang P; Nasr SH; Sathick IJ; Kittanamongkolchai W; Kurtin PJ; Alexander MP; Cornell LD; Fidler ME; Grande JP; Herrera Hernandez LP; Said SM; Sethi S; Dispenzieri A; Gertz MA; Leung N
Kidney Int; 2019 Oct; 96(4):1005-1009. PubMed ID: 31447055
[TBL] [Abstract][Full Text] [Related]
30. Significant association between renal function and area of amyloid deposition evident in kidney biopsy specimens in both AA and AL amyloidosis.
Kuroda T; Ito Y; Imai N; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ueno M; Nakano M; Narita I
Amyloid; 2017 Mar; 24(sup1):151-152. PubMed ID: 28434330
[No Abstract] [Full Text] [Related]
31. Progressive chorioretinal involvement in a patient with light-chain (AL) amyloidosis: a case report.
Augstburger E; Sahel JA; Audo I
BMC Ophthalmol; 2020 Feb; 20(1):59. PubMed ID: 32085748
[TBL] [Abstract][Full Text] [Related]
32. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
34. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
[TBL] [Abstract][Full Text] [Related]
35. Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsy.
Charitaki E; Kastritis E; Petraki C; Liapis K; Adamidis K; Apostolou T; Christodoulidou C; Nikolopoulou N; Terpos E; Nakopoulou L; Dimopoulos MA
Clin Nephrol; 2016 Jan; 85(1):44-54. PubMed ID: 26587779
[TBL] [Abstract][Full Text] [Related]
36. Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor.
Rezk T; Lachmann HJ; Fontana M; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Foard D; Lane T; Youngstein T; Wechalekar AD; Bass P; Hawkins PN; Gillmore JD
Kidney Int; 2017 Dec; 92(6):1476-1483. PubMed ID: 28729034
[TBL] [Abstract][Full Text] [Related]
37. Multiorgan involvement by amyloid light chain amyloidosis.
Li G; Han D; Wei S; Wang H; Chen L
J Int Med Res; 2019 Apr; 47(4):1778-1786. PubMed ID: 30803274
[TBL] [Abstract][Full Text] [Related]
38. Correlation between amyloid deposits affecting renal compartments and glomerular filtration rate during renal biopsy in a renal amyloidosis case series.
Fonseca EO; Caldas MLR; Soares Filho PJ; Almeida JR
Braz J Med Biol Res; 2020; 53(6):e8625. PubMed ID: 32428129
[TBL] [Abstract][Full Text] [Related]
39. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
Cagnoli L;
G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
[TBL] [Abstract][Full Text] [Related]
40. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.
Uda H; Yokota A; Kobayashi K; Miyake T; Fushimi H; Maeda A; Saiki O
J Rheumatol; 2006 Aug; 33(8):1482-7. PubMed ID: 16881107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
